Article Correctness Is Author's Responsibility: Cancer trial led by University of Minnesota Medical School’s Dr. Clark Chen shows promise

(University of Minnesota Medical School) New data from a Phase I clinical trial led by Clark Chen, M.D., Ph.D., Lyle French Chair in Neurosurgery and Head of the University of Minnesota Medical School Department of Neurosurgery shows more than a quarter of patients with recurrent high-grade glioma, a form of brain cancer, were alive more than three years after treatment.